Cytokine Release Syndrome and Immune-Related Pneumonitis Associated With Tumor Progression in a Pulmonary Pleomorphic Carcinoma Treated With Nivolumab Plus Ipilimumab Treatment: A Case Report

Effective control of severe immune-related adverse events, including cytokine release syndrome (CRS), is essential for the success of immunotherapy. We present a case of a granulocyte colony-stimulating factor–producing pleomorphic lung carcinoma treated with nivolumab plus ipilimumab which develope...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunimasa, Kei, Inoue, Takako, Matsueda, Katsunori, Kawamura, Takahisa, Tamiya, Motohiro, Nishino, Kazumi, Kumagai, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763637/
https://www.ncbi.nlm.nih.gov/pubmed/35072122
http://dx.doi.org/10.1016/j.jtocrr.2021.100272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763637/
https://www.ncbi.nlm.nih.gov/pubmed/35072122
http://dx.doi.org/10.1016/j.jtocrr.2021.100272

Ejemplares similares